نتائج البحث

Neoadjuvant inetetamab and pertuzumab with taxanes and carboplatin (TCbIP) In locally advanced HER2-positive breast cancer: a prospective cohort study with propensity-matched analysis.

• Authors : Jiang, Mingxia¹ (AUTHOR); Chai, Yue¹ (AUTHOR); Liu, Jiaxuan¹ (AUTHOR)

• Source: BMC Cancer. 7/22/2024, Vol. 24 Issue 1, p1-12. 12p.

تفاصيل العنوان

A survey of carboplatin desensitization therapy in Japan: A multicenter retrospective study.

• Authors : Komatsu, Hiroaki¹ (AUTHOR) ; Matsumoto, Koji² (AUTHOR) ‐cc.jp; Morita, Mitsunori² (AUTHOR)

• Source: Cancer Medicine. Mar2024, Vol. 13 Issue 5, p1-9. 9p.

تفاصيل العنوان

Combination of Cisplatin and Temozolomide versus Carboplatin and Etoposide in the Treatment of Recurrent High Grade Glioma Patients.

• Authors : Elwan, Amira¹ ; Embaby, Ahmed²; Bakry, Adel S.³

Subjects: *TEMOZOLOMIDE; *CISPLATIN; *CARBOPLATIN

• Source: Zagazig University Medical Journal. Jan/Feb2024, Vol. 30 Issue 1, p34-41. 8p.

تفاصيل العنوان

Development and Evaluation of a Quantitative Systems Pharmacology Model for Mechanism Interpretation and Efficacy Prediction of Atezolizumab in Combination with Carboplatin and Nab-Paclitaxel in Patients with Non-Small-Cell Lung Cancer.

• Authors : Wang, Chen-Yu¹ (AUTHOR) ; Dai, Hao-Ran¹ (AUTHOR) ; Tan, Yu-Ping¹ (AUTHOR)

• Source: Pharmaceuticals (14248247). Feb2024, Vol. 17 Issue 2, p238. 12p.

تفاصيل العنوان

De-escalation of neoadjuvant taxane and carboplatin therapy in HER2-positive breast cancer with dual HER2 blockade: a multicenter real-world experience in China.

• Authors : Wu S; Department of Breast Oncology, The Fifth Medical Center of Chinese PLA General Hospital, No.8 East Street, Beijing, 100071, China.; Bian L

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/pathology ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/metabolism

• Source: World journal of surgical oncology [World J Surg Oncol] 2024 Aug 21; Vol. 22 (1), pp. 214. Date of Electronic Publication: 2024 Aug 21.Publisher: BioMed Central Country of Publication: England NLM ID: 101170544 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7819

تفاصيل العنوان

Clinical and safety outcomes of BeEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) versus CEM (Carboplatin, Etoposide, Melphalan) in lymphoma patients as a conditioning regimen before autologous hematopoietic cell transplantation.

• Authors : Eltelbanei MA; Senior Clinical Pharmacist in Hematology, Oncology, and Stem Cell Transplantation at International Medical Center (IMC) Hospital, Clinical pharmacy & pharmacy practice master candidate at Faculty of pharmacy, Damanhour University, Cairo, Egypt. .; El-Bassiouny NA

Subjects: Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/methods ; Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/adverse effects ; Cytarabine*/Cytarabine*/Cytarabine*/administration & dosage

• Source: BMC cancer [BMC Cancer] 2024 Aug 13; Vol. 24 (1), pp. 1002. Date of Electronic Publication: 2024 Aug 13.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان

ENDOLUNG trial. A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial cancer.

• Authors : Leary A; Medical Oncology, Institut Gustave Roussy, Villejuif, France.; Estévez-García P

Subjects: Paclitaxel*/Paclitaxel*/Paclitaxel*/administration & dosage ; Paclitaxel*/Paclitaxel*/Paclitaxel*/therapeutic use ; Paclitaxel*/Paclitaxel*/Paclitaxel*/adverse effects

• Source: BMC cancer [BMC Cancer] 2024 Jul 22; Vol. 24 (1), pp. 876. Date of Electronic Publication: 2024 Jul 22.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان

A propensity score-matched comparison of neoadjuvant chemoradiotherapy with cisplatin-5FU and carboplatin-paclitaxel in locally advanced esophageal squamous cell carcinoma: A Turkish oncology group study.

• Authors : Gürler F; Department of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Turkey.; Tay F

Subjects: Propensity Score* ; Carboplatin*/Carboplatin*/Carboplatin*/administration & dosage ; Cisplatin*/Cisplatin*/Cisplatin*/administration & dosage

• Source: Cancer medicine [Cancer Med] 2024 Jul; Vol. 13 (14), pp. e70002.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

Intraarterial Carboplatin + Caelyx vs Intraarterial Carboplatin + Etoposide Phosphate for Progressing Glioblastoma

• Authors : David Fortin, Full professor in surgery

• Source: Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG,

تفاصيل العنوان

A Study of Tiragolumab in Combination With Atezolizumab Plus Pemetrexed and Carboplatin/Cisplatin Versus Pembrolizumab Plus Pemetrexed and Carboplatin/Cisplatin in Participants With Previously Untreated Advanced Non-Squamous Non-Small Cell Lung Cancer (SKYSCRAPER-06)

• Source: A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Study of Tiragolumab in Combination With Atezolizumab Plus Pemetrexed and Carboplatin/Cisplatin Versus

تفاصيل العنوان